文献速递前列腺增生与排尿功能障碍

成人膀胱过度活动症患者的睡眠障碍:一项横断面调查

Sleep Disturbance Among Adults With Overactive Bladder: A Cross-sectional Survey.
PubMed 文献 · Urology · 2023-06-23

该横断面调查纳入接受抗胆碱能药、β-3肾上腺素能激动剂或无治疗的成人膀胱过度活动症(OAB)患者各100例,评估睡眠障碍、夜尿症和抑郁。三个治疗组在所有PROMIS领域的症状评分均高于美国一般人群,但组间差异无统计学意义;米拉贝隆组在所有结局上呈症状影响最低的趋势,但比较未达显著。

要点

  • 成人OAB患者无论接受何种治疗,均报告受睡眠障碍和抑郁影响。
  • 三个治疗组在所有PROMIS领域的症状评分均高于美国一般人群。
  • 米拉贝隆组在所有结局上呈症状影响最低的趋势,但比较无统计学显著差异。

核心结论

  • 成人OAB患者无论接受何种治疗,均报告受睡眠障碍和抑郁影响。
  • 米拉贝隆组在所有结局上呈症状影响最低的趋势,但比较未达统计学显著。
  • 未来研究应考察OAB治疗、睡眠障碍与结局之间的时间关联。

研究设计与样本

  • 横断面调查,纳入成人OAB患者,按治疗方式分为抗胆碱能药组、β-3肾上腺素能激动剂组和无治疗组,每组100例。
  • 使用PROMIS-29 Profile v2.1(睡眠障碍和抑郁领域)、下尿路功能障碍研究网络症状指数-10和PROMIS睡眠障碍简表8B等患者报告结局工具评估。
  • 采用协方差分析(ANCOVA)检验研究终点差异,并行Bonferroni校正的成对检验(P < .05/3)比较组间最小二乘均值差异。

主要发现

  • 所有组总体平均(标准差)年龄为47.8(11.8)岁。
  • 三个治疗组在所有PROMIS领域的症状评分均高于美国一般人群。
  • 各治疗组间结局无统计学显著差异。
  • 米拉贝隆组在所有结局上呈症状影响最低的趋势,但比较未达统计学显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine differences in sleep disturbance, nocturia, and depression among adults with overactive bladder (OAB) by treatment type. METHODS: A cross-sectional survey of adults with OAB assessed sleep disturbance, nocturia, and depression using patient-reported outcome measures, including the Patient Reported Outcomes Measurement Information System (PROMIS)-29 Profile v2.1 (Sleep Disturbance and Depression domains), Lower Urinary Tract Dysfunction Research Network Symptom Index-10, and PROMIS Sleep Disturbance Short Form 8B. Treatment groups included antimuscarinics, β-3 adrenergic agonists, and no treatment. Analysis of covariance (ANCOVA) was used to test for differences in study endpoints; Bonferroni-adjusted pairwise tests (P < .05/3) were performed to compare differences in least squares means between groups. RESULTS: One hundred participants were included per treatment group. The overall mean (standard deviation) age across all groups was 47.8 (11.8) years. Symptom scores across all PROMIS domains in all three treatment groups were higher than the US general population. There were no statistically significant differences in outcomes across treatment groups. CONCLUSION: Adults with OAB reported being affected by sleep disturbance and depression, regardless of treatment. The mirabegron group trended toward the lowest symptom impact across all outcomes, however, comparisons were not significant. Future research should examine temporal associations between OAB treatment, sleep disturbance, and outcomes.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lai HH, Walker D, Elsouda D, et al. Sleep Disturbance Among Adults With Overactive Bladder: A Cross-sectional Survey. Urology. 2023. PMID: 37356462. doi:10.1016/j.urology.2023.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。